People

Cutera Welcomes Jeryl Hilleman to its Board of Directors

New member most recently worked as CFO of Intersect ENT Inc.

By: Michael Barbella

Managing Editor

Cutera Inc.’s newest board member, Jeryl “Jeri” Hilleman, will officially join the governing body in about a week.

Hilleman has more than 30 years of healthcare industry experience, with a proven track record in financial leadership, strategic planning, operational excellence, and corporate governance. Her extensive background in life sciences and medical technology, both as a public company chief financial officer (CFO) and as a corporate director, will be invaluable to Cutera as it continues to innovate, drive toward profitability, and expand its market presence with AviClear and other flagship products.

Hilleman will officially assume her board position on July 12.

“We are thrilled to welcome Jeri to our Board of Directors,” Cutera CEO Taylor Harris said. “Her deep understanding of the healthcare sector, combined with her financial acumen and operational insights, will be instrumental in guiding Cutera through our next phase of growth. Jeri’s expertise aligns perfectly with our commitment to delivering value to our shareholders and advancing our patient-focused and customer-centric mission within the medical aesthetics field.”

Hilleman had served as a public company CFO for nearly 20 years. Most recently, she was CFO of Intersect ENT Inc., a commercial drug delivery company focusing on patients with ear, nose and throat conditions. Prior to Intersect ENT, Hilleman served as CFO of other public healthcare companies including Ocera Therapeutics Inc., a biopharmaceutical company; Amyris Inc., a renewable products company; and Symyx Technologies, a life sciences automation company. Her leadership has been pivotal in multiple successful capital-raising events and M&A transactions.

Hilleman also brings significant corporate governance experience to the Cutera board. She has served as the board chair for Omada Health, as well as the Audit Committee chair of multiple companies including NovoCure, Limited, Minerva Neurosciences, HilleVax, SI-Bone, and XenoPort.

Hilleman earned a bachelor of arts degree in history from Brown University and an MBA from the Wharton School at the University of Pennsylvania.

“I am excited to join Cutera’s Board at this time,” Hilleman stated. “Cutera’s products and market position offer tremendous potential. I look forward to working with the board and management team to drive growth and profitability, enhance operational efficiency, and create long-term value for our investors.”

Cutera provides aesthetic and dermatology solutions for practitioners worldwide. The company is based in Brisbane, Calif.

 

 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters